|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 181 - 210 of 254 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
PL
|
Resepti
|
Rivaxa 15 mg + 20 mg tabletti, kalvopäällysteinen (aloituspakkaus) SPC 2024-03-15.docx
|
|
PL
|
Resepti
|
Rivaxa 15 mg tabletti, kalvopäällysteinen SPC 2024-06-21
|
|
PL
|
Resepti
|
Rivaxa 2,5 mg tabletti, kalvopäällysteinen SPC 2024-03-15.docx
|
|
PL
|
Resepti
|
Rivaxa 20 mg tabletti, kalvopäällysteinen SPC 2024-06-21
|
|
|
|
European Medicines Agency's website:
Rixathon - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Riximyo - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Riximyo - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Rixubis - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Rizastad 10 mg tabletti, suussa hajoava SPC 2024-04-12
|
|
PL
|
Resepti
|
Rizatriptan Stada 10 mg tabletti SPC 2024-04-11
|
|
|
|
European Medicines Agency's website:
Rizmoic - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
RoActemra - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Robinul 0,2 mg-ml injektioneste, liuos SPC 2021-10-01
|
|
PL
|
Resepti
|
Robinul-Neostigmin 0.5 mg-ml + 2.5 mg-ml injektioneste, liuos SPC 2023-06-01
|
|
PL
|
Resepti
|
Rocephalin cum lidocain 1 g injektiokuiva-aine ja liuotin, liuosta varten SPC 2024-08-21
|
|
|
|
European Medicines Agency's website:
Roclanda - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Roctavian - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Rocuronium B.Braun 10 mg-ml injektio-infuusioneste, liuos SPC 2024-03-22
|
|
PL
|
Resepti
|
Rocuronium bromide Aguettant 10 mg-ml injektioneste, liuos, esitäytetty ruisku SPC 2024-07-24
|
|
PL
|
Resepti
|
Rocuronium Fresenius Kabi 10 mg-ml injektio - infuusioneste, liuos SPC 2024-01-26
|
|
PL
|
Resepti
|
Rocuronium hameln 10 mg - ml injektio - infuusioneste, liuos SPC 2023-12-05
|
|
PL
|
Itsehoito
|
Rogaine 50 mg-ml liuos iholle SPC 2022-10-03
|
|
|
|
European Medicines Agency's website:
Rolufta Ellipta - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Itsehoito
|
Rometor ratiopharm 2 mg-ml oraaliliuos SPC 2022-10-04
|
|
|
|
European Medicines Agency's website:
Ronapreve - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Ropinirol KRKA 2 mg, 4 mg, 8 mg, depottabletti SPC 2023-05-29
|
|
PL
|
Resepti
|
Ropinirol Orion 2 mg, 4 mg, 8 mg depottabletti SPC 2023-10-09
|
|
PL
|
Resepti
|
Ropinostad 2 mg, 4 mg, 8 mg depottabletti SPC 2023-05-30
|
|
PL
|
Resepti
|
Ropivacain Fresenius Kabi 2 mg-ml infuusioneste, liuos SPC 2023-08-23
|
|
PL
|
Resepti
|
Ropivacain Fresenius Kabi 2 mg-ml, 7.5 mg-ml, 10 mg-ml injektioneste, liuos SPC 2023-08-23
|
|
|
| |
